当前位置: 首页 >> 检索结果
共有 320 条符合本次的查询结果, 用时 2.7020349 秒

121. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2014年160卷8期558-64页
Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on vitamin supplementation to prevent cardiovascular disease and cancer.

122. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

作者: Neil J Stone.;Jennifer G Robinson.;Alice H Lichtenstein.;David C Goff.;Donald M Lloyd-Jones.;Sidney C Smith.;Conrad Blum.;J Sanford Schwartz.; .
来源: Ann Intern Med. 2014年160卷5期339-43页
In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce cardiovascular risk in adults. This synopsis summarizes the major recommendations.

123. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2014年160卷6期414-20页
Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus (GDM).

124. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2014年160卷5期330-8页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer.

125. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2014年160卷4期271-81页
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

126. Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷7期484-9页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for glaucoma.

127. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline.

作者: Marcello Tonelli.;Christoph Wanner.; .
来源: Ann Intern Med. 2014年160卷3期182页
The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2013 on lipid management and treatment of all adults and children with chronic kidney disease (CKD). All forms of CKD are included (non-dialysis-dependent, dialysis-dependent, and kidney transplant recipients).

128. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians.

作者: Amir Qaseem.;Linda L Humphrey.;Nick Fitterman.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷11期770-779页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease.

129. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2014年160卷1期55-60页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for oral cancer.

130. Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee.

作者: Thomas R Talbot.;Dale W Bratzler.;Ruth M Carrico.;Daniel J Diekema.;Mary K Hayden.;Susan S Huang.;Deborah S Yokoe.;Neil O Fishman.; .
来源: Ann Intern Med. 2013年159卷9期631-5页
Health care-associated infection (HAI) rates are used as measures of a health care facility's quality of patient care. Recently, these outcomes have been used to publicly rank quality efforts and determine facility reimbursement. The value of comparing HAI rates among health care facilities is limited by many factors inherent to HAI surveillance, and incentives that reward low HAI rates can lead to unintended consequences that can compromise medical care surveillance efforts, such as the use of clinical adjudication panels to veto events that meet HAI surveillance definitions.The Healthcare Infection Control Practices Advisory Committee, a federal advisory committee that provides advice and guidance to the Centers for Disease Control and Prevention (CDC) and the Secretary of the Department of Health and Human Services about strategies for surveillance, prevention, and control of HAIs, assessed the challenges associated with using HAI surveillance data for external quality reporting, including the unintended consequences of clinician veto and clinical adjudication panels. Discussions with stakeholder liaisons and committee members were then used to formulate recommended standards for the use of HAI surveillance data for external facility assessment to ensure valid comparisons and to provide as level a playing field as possible.The final recommendations advocate for consistent, objective, and independent application of CDC HAI definitions with concomitant validation of HAIs and surveillance processes. The use of clinician veto and adjudication is discouraged.

131. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.

作者: Amir Qaseem.;Robert H Hopkins.;Donna E Sweet.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷12期835-47页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease.

132. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷9期613-9页
Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for high blood pressure in children and adolescents.

133. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷10期698-708页
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on the use of medications for breast cancer risk reduction.

134. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians.

作者: Amir Qaseem.;Jon-Erik C Holty.;Douglas K Owens.;Paul Dallas.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷7期471-83页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of obstructive sleep apnea (OSA) in adults.

135. Principles supporting dynamic clinical care teams: an American College of Physicians position paper.

作者: Robert B Doherty.;Ryan A Crowley.; .
来源: Ann Intern Med. 2013年159卷9期620-6页
The U.S. health care system is undergoing a shift from individual clinical practice toward team-based care. This move toward team-based care requires fresh thinking about clinical leadership and responsibilities to ensure that the unique skills of each clinician are used to provide the best care for the patient as the patient's needs dictate, while the team as a whole must work together to ensure that all aspects of a patient's care are coordinated for the benefit of the patient. In this position paper, the American College of Physicians offers principles, definitions, and examples to dissolve barriers that prevent movement toward dynamic clinical care teams. These principles offer a framework for an evolving, updated approach to health care delivery, providing policy guidance that can be useful to clinical teams in organizing the care processes and clinician responsibilities consistent with professionalism.

136. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷5期342-8页
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for peripheral artery disease (PAD).

137. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷5期349-57页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults.

138. Primary care interventions to prevent child maltreatment: U.S. Preventive Services Task Force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷4期289-95页
Chinese translation

139. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

作者: Paul E Stevens.;Adeera Levin.; .
来源: Ann Intern Med. 2013年158卷11期825-30页
The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed clinical practice guidelines in 2012 to provide guidance on the evaluation, management, and treatment of chronic kidney disease (CKD) in adults and children who are not receiving renal replacement therapy.

140. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement.

作者: Virginia A Moyer.; .
来源: Ann Intern Med. 2013年159卷3期210-8页
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening and behavioral counseling interventions in primary care to reduce alcohol misuse.
共有 320 条符合本次的查询结果, 用时 2.7020349 秒